Supported by its capable investor partners and strengthened by a third round of financing in 2010, JenaValve has raised a total of € 32.5 million to support product finalization, patent and marketing activities, pre-clinical and clinical trials and serial production. The investors in JenaValve:
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
